LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
There were many days I did not have energy to do anything but to sit or lay on the sofa and watch television
(cymbiotika.com) Taking B vitamins with glutathione ensures that the underlying "gears" of your cellular chemistry are turning
The peptide binds to GLP-1 receptors throughout the body, triggering a cascade of metabolic effects that include increased insulin secretion, decreased glucagon release, delayed gastric emptying, and reduced appetite signaling in the hypothalamus
"As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth"